828 related articles for article (PubMed ID: 17877951)
21. Endocrine therapy for early breast cancer.
Hussain SA; Williams S; Stevens A; Rea DW
Expert Rev Anticancer Ther; 2004 Oct; 4(5):877-88. PubMed ID: 15485321
[TBL] [Abstract][Full Text] [Related]
22. Risk reduction of distant metastasis in hormone-sensitive postmenopausal breast cancer.
Toi M; Yamashiro H; Tsuji W
Breast Cancer; 2009; 16(3):207-18. PubMed ID: 19259765
[TBL] [Abstract][Full Text] [Related]
23. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.
Booth CM; Pater JL; Goss PE
Cancer; 2007 May; 109(9):1927-8; author reply 1928. PubMed ID: 17354227
[No Abstract] [Full Text] [Related]
24. Combined ovarian ablation and aromatase inhibition as first-line therapy for hormone receptor-positive metastatic breast cancer in premenopausal women: report of three cases.
El-Saghir NS; El-Hajj II; Makarem JA; Otrock ZK
Anticancer Drugs; 2006 Sep; 17(8):999-1002. PubMed ID: 16940812
[TBL] [Abstract][Full Text] [Related]
25. Molecularly targeted endocrine therapies for breast cancer.
Orlando L; Schiavone P; Fedele P; Calvani N; Nacci A; Rizzo P; Marino A; D'Amico M; Sponziello F; Mazzoni E; Cinefra M; Fazio N; Maiello E; Silvestris N; Colucci G; Cinieri S
Cancer Treat Rev; 2010 Nov; 36 Suppl 3():S67-71. PubMed ID: 21129614
[TBL] [Abstract][Full Text] [Related]
26. [Future endocrine therapy of breast cancer].
Ejlertsen B
Ugeskr Laeger; 2007 Jan; 169(4):296. PubMed ID: 17274921
[No Abstract] [Full Text] [Related]
27. The choice of systemic adjuvant therapy in receptor-positive early breast cancer.
Dellapasqua S; Castiglione-Gertsch M
Eur J Cancer; 2005 Feb; 41(3):357-64. PubMed ID: 15691634
[TBL] [Abstract][Full Text] [Related]
28. Reducing the risk of distant metastases: a better end point in adjuvant aromatase inhibitor breast cancer trials?
Tang SC
Cancer Invest; 2008 Jun; 26(5):481-90. PubMed ID: 18568770
[TBL] [Abstract][Full Text] [Related]
29. [The use of GnRH analogues in early and advanced breast carcinomas].
Ségura C; Avenin D; Gligorov J; Selle F; Estéso A; Beerblock K; Emile G; Do Huyen N; Lotz JP
Gynecol Obstet Fertil; 2005 Nov; 33(11):914-9. PubMed ID: 16246613
[TBL] [Abstract][Full Text] [Related]
30. Adjuvant endocrine therapy for perimenopausal women with early breast cancer.
Ortmann O; Cufer T; Dixon JM; Maass N; Marchetti P; Pagani O; Pronzato P; Semiglazov V; Spano JP; Vrdoljak E; Wildiers H
Breast; 2009 Feb; 18(1):2-7. PubMed ID: 19036588
[TBL] [Abstract][Full Text] [Related]
31. Adjuvant endocrine therapy for premenopausal women with early breast cancer.
Dellapasqua S; Colleoni M; Gelber RD; Goldhirsch A
J Clin Oncol; 2005 Mar; 23(8):1736-50. PubMed ID: 15755982
[No Abstract] [Full Text] [Related]
32. Prevention of hormone-related cancers: breast cancer.
Dunn BK; Wickerham DL; Ford LG
J Clin Oncol; 2005 Jan; 23(2):357-67. PubMed ID: 15637398
[TBL] [Abstract][Full Text] [Related]
33. [Developments in endocrine therapy for breast cancer].
Matsui A; Ikeda T; Jinno H; Tajima G; Hohjou T; Tokura H; Mitsui Y; Asaga S; Muto T; Kitajima M
Gan To Kagaku Ryoho; 2002 Jul; 29(7):1138-45. PubMed ID: 12145993
[TBL] [Abstract][Full Text] [Related]
34. Insights on adjuvant endocrine therapy for premenopausal and postmenopausal breast cancer.
Briest S; Wolff AC
Expert Rev Anticancer Ther; 2007 Sep; 7(9):1243-53. PubMed ID: 17892424
[TBL] [Abstract][Full Text] [Related]
35. A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.
Younus J; Vandenberg TA
Bull Cancer; 2005 Apr; 92(4):E39-44. PubMed ID: 15888383
[TBL] [Abstract][Full Text] [Related]
36. Clinical use of selective estrogen receptor modulators and down regulators with the main focus on breast cancer.
Baumann CK; Castiglione-Gertsch M
Minerva Ginecol; 2009 Dec; 61(6):517-39. PubMed ID: 19942839
[TBL] [Abstract][Full Text] [Related]
37. Managing patients on endocrine therapy: focus on quality-of-life issues.
Whelan TJ; Pritchard KI
Clin Cancer Res; 2006 Feb; 12(3 Pt 2):1056s-1060s. PubMed ID: 16467124
[TBL] [Abstract][Full Text] [Related]
38. Hormonal therapy for postmenopausal breast cancer: the science of sequencing.
Miller WR; Bartlett JM; Canney P; Verrill M
Breast Cancer Res Treat; 2007 Jun; 103(2):149-60. PubMed ID: 17039263
[TBL] [Abstract][Full Text] [Related]
39. Adjuvant endocrine therapy for early breast cancer: the story so far.
Gradishar WJ
Cancer Invest; 2010 May; 28(4):433-42. PubMed ID: 20307199
[TBL] [Abstract][Full Text] [Related]
40. Adherence to long-term adjuvant hormonal therapy for breast cancer.
Gotay C; Dunn J
Expert Rev Pharmacoecon Outcomes Res; 2011 Dec; 11(6):709-15. PubMed ID: 22098287
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
